MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth

This publication has 33 references indexed in Scilit:

• CLONING AND FUNCTIONAL CHARACTERIZATION OF A NOVEL c-mpl VARIANT EXPRESSED IN HUMAN CD34 CELLS AND PLATELETS
  Cytokine, 2000
• Dominant negative effect of a truncated erythropoietin receptor (EPOR-T) on erythropoietin-induced erythroid differentiation
  Experimental Hematology, 1999
• Study of the thrombopoietin receptor in essential thrombocythemia
  Leukemia, 1997
• Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å
  Science, 1996
• Recombinant human megakaryocyte growth and development factor (rhumgdf), a ligand for c‐mpl, produces functional human platelets in vitro
  The International Journal of Cell Cloning, 1995
• Thrombocytopenia in c-mpl-deficient mice
  Science, 1994
• Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin
  Nature, 1994
• Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
  Nature, 1994
• IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo
  Cell, 1985
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
  Biochemical and Biophysical Research Communications, 1978